Why is early goal-directed therapy successful – is it the technology?
Critical Care volume 9, Article number: 307 (2005)
When assessing outcome studies, the beneficial portion of any therapeutic strategy may not be clearly identified, especially in a condition as complex as sepsis. In the randomized controlled trial conducted by Rivers and coworkers , early goal-directed therapy (EGDT) was associated with significantly improved outcomes in sepsis. The study group received a package of care that focused on early resuscitation for the first 6 hours as an inpatient. This comprised fluid, including blood, pressors and inotropes. The goals of resuscitation were based on hemodynamic variables and central venous oxygen saturation (Scvo2). The technology used to measure this was a central venous catheter with integrated oximetry. This device is examined in this issue of Critical Care . In keeping with the style we previously adopted for technology assessment reviews, the article begins with a Q&A from the industry.
Early resuscitation in sepsis is standard practice . If the treatment effect reported by Rivers and coworkers is not due to bias in the study design, then to what part(s) of the resuscitation 'package' is the benefit attributable? Opinions vary regarding the contribution an oximetric catheter makes in severe sepsis . Previous studies of therapy directed by mixed venous saturation have found no similar improvement in outcome [5, 6]. It seems more likely to us that the timing of resuscitation is the crucial aspect rather than the technology employed [7, 8].
Another aspect of the study by Rivers and colleagues that has attracted discussion is the difference in the use of blood transfusion between the groups. The use of blood to improve oxygen delivery is controversial; a liberal transfusion strategy is not beneficial in general intensive care patients  and the ability of stored red cells to improve oxygen delivery acutely is known to be impaired . Finally, although blinding in a trial of resuscitation is very difficult to achieve, unfortunately the capacity for this methodological shortcoming to introduce bias remains undiminished.
In light of these considerations, we present a review, paired with the Q&A, which forms part of a process of critical review that any new health technology should be subjected to by the critical care community. In our view, we must remain critical; ScvO2 monitoring cannot be assumed to be central to the success of EGDT . Other goals are presented in the review that are feasible and less invasive. It will take time for ScvO2 monitoring to find its rightful place.
early goal-directed therapy
central venous oxygen saturation.
Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M, the Early Goal-Directed Therapy Collaborative Group: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345: 1368-1377. 10.1056/NEJMoa010307
Gunn SR, Fink MP: Equipment review: The success of early goal-directed therapy for septic shock prompts evaluation of current approaches for monitoring the adequacy of resuscitation. Crit Care 2005, in press.
Dellinger RPM, Carlet JMM, Masur HM, Gerlach HM, Calandra TM, Cohen JM, Gea-Banacloche JMP, Keh DM, Marshall JCM, Parker MMM, for the Surviving Sepsis Campaign Management Guidelines Committee, et al.: Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004, 32: 858-873. 10.1097/01.CCM.0000117317.18092.E4
Marik PE, Varon J, Abroug F, Besbes L, Nouira S, Sarkar S, Kupfer Y, Tessler S, Rivers EP, Nguyen HB: Goal-directed therapy for severe sepsis. N Engl J Med 2002, 346: 1025-1026. 10.1056/NEJM200203283461314
Hayes MA, Timmins AC, Yau E, Palazzo M, Hinds CJ, Watson D: Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994, 330: 1717-1722. 10.1056/NEJM199406163302404
Gattinoni L, Brazzi L, Pelosi P, Latini R, Tognoni G, Pesenti A, Fumagalli R, The S: A trial of goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med 1995, 333: 1025-1032. 10.1056/NEJM199510193331601
Boyd O, Grounds RM, Bennett ED: A randomized clinical trial of the effect of deliberate perioperative increase of oxygen delivery on mortality in high-risk surgical patients. JAMA 1993, 270: 2699-2707. 10.1001/jama.270.22.2699
Wilson J, Woods I, Fawcett J, Whall R, Dibb W, Morris C, McManus E: Reducing the risk of major elective surgery: randomised controlled trial of preoperative optimisation of oxygen delivery. BMJ 1999, 318: 1099-1103.
Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E, The Transfusion Requirements in Critical Care Investigators for the Canadian Critical Care Trials Group: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999, 340: 409-417. 10.1056/NEJM199902113400601
Marik PE, Sibbald WJ: Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA 1993, 269: 3024-3029. 10.1001/jama.269.23.3024
Rhodes A, Bennett ED: Early goal-directed therapy: an evidence-based review. Crit Care Med 2004, (Suppl):S448-S450. 10.1097/01.CCM.0000145945.39002.8D
The author(s) declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
Chapman, M., Gattas, D. & Suntharalingam, G. Why is early goal-directed therapy successful – is it the technology?. Crit Care 9, 307 (2005). https://doi.org/10.1186/cc3726